Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs JetBlue Airways Corporation (JBLU) Price & Performance

BridgeBio Pharma IncTrade
JetBlue Airways CorporationTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs JetBlue Airways Corporation — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while JetBlue Airways Corporation trades at $5.81 (market cap $2.19B). The key difference: BridgeBio Pharma Inc is far larger — about 7.5× JetBlue Airways Corporation's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.

BBIOJBLU
Market Cap
$16.36B$2.19B
Sector
HealthIndustrials
52-Week High
$90.17$6.46
52-Week Low
$47.29$4.03
Enterprise Value
$18.14B$9.56B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.

Read more on JBLU